Former Novartis Consumer Health Israel CEO Estee Rosen Joins Sativus Tech

Sativus Tech Corporation

Estee Rosen

Estee Rosen, Formerly Novartis Consumer Health Israel, Joins Sativus Tech

Estee Rosen, Formerly Novartis Consumer Health Israel, Joins Sativus Tech

Rosen’s appointment strengthens Kesar Tech’s position as the company looks to Accelerate Your Growth Strategy And drive revenues,

TEL AVIV, Israel, November 21, 2022 (GLOBE NewsWire) — Sativus Tech (SATT), the only AgTech company that has successfully grown saffron using its advanced vertical farming technology, today announced that it has acquired Estee Rosen, a subsidiary of Sativus Tech, for its business in wellness, health and beauty for Saffron Tech. Appointed as Head of Development. , In this role, Estee will lead Saffron Tech’s go-to-market approach to the wellness, health and beauty markets while creating key partnerships to generate revenue as part of the company’s go-to-market strategy.

“Asti is an outstanding addition to the Saffron Tech team, bringing a dynamic mix of leadership experience as we enter the B2B marketplace,” said Tal Wilk-Glazer, CEO of Sativus Tech. “Her leadership experience will be critical in successfully developing new markets as Sativus Tech focuses on rapid growth and global expansion. It is a great opportunity to have Asti join the team at this important time, and we welcome her to join the team.”

Estee has over 20 years of leadership experience in the healthcare industry. She previously served as CEO of Novartis Consumer Health Israel and founded health-care companies Blueyes and BluPharma. His experience in the healthcare sector will help Kesar Tech as it seeks to meet the growing demand for saffron in food supplements, cosmetics and wellness products.

Saffron is known for its anti-anxiety, antidepressant and antioxidant properties. Saffron Tech can supply a consistent, high-grade and large-scale supply of Saffron to the health, wellness and beauty industries.

“I am excited to join the Saffron Tech team and help establish a solid foundation that can attract new business in the health, wellness and beauty space,” said Estee Rosen. “I believe that saffron has the potential to bring an alternative, natural treatment to those suffering from depression and anxiety and I am delighted to join this team to bring this vision to reality. I look forward to exploring all avenues that can lead to global expansion and revenue.

About Sativus Tech Corp:

Sativus Tech Corp (OTC: SATT) is an AgTech company that uses its advanced vertical farming technology to increase the production of low-yield food products for the global market. The company focuses on research, development and commercialization of agricultural products that are in high demand but short in supply. The reliable production of these highly coveted food products can be used in a variety of applications including the pharmaceutical, nutraceutical, culinary, beauty, health and wellness industries. Sativus Tech Corp.’s technology offers a responsible and sustainable way to grow crops in a world grappling with environmental challenges and dwindling earth reserves, dwindling water sources and unstable weather conditions.

Saffron Tech, a subsidiary of Sativus Tech Corp., is revolutionizing the agtech world by creating a protocol for growing saffron in indoor vertical farms. It is also increasing the production of spices by multiplying the number of annual harvests. The pharmaceutical industry is now turning its more scientific attention to the medicinal properties of saffron, which is now being used in pharmaceutical and nutraceutical applications for ADHD, anxiety and more.

forward-looking statements:

All statements other than statements of historical fact contained in this press release are “forward-looking statements,” which can often, but not always, be identified by the use of words such as “expects,” “estimates,” “will.” “estimates,” “plans,” “potential,” “possible,” “potential,” “believes,” “wants,” “might,” “will,” “should,” “could” or the negative or other similar sense of such words. These statements involve known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. These factors include uncertainties as to the Company’s international manufacturing and supply chain, market acceptance of the Company’s smart goods, successfully implementing the Company’s growth strategy, reliance on the Company’s key personnel, changes in economic conditions, competition and other risks , but are not limited to. , which are described in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 11, 2022 (“SEC”) and other filings and submissions with the SEC. These forward-looking statements speak only as of the date hereof and the company disclaims any obligation to update these statements except as required by law. The company intends that all forward-looking statements will be subject to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.

Investor Relations Contact:

Tal Wilk Glazer

chief executive officer

[email protected]

800-608-6432

attachment

Leave a Comment